Espicom market intelligence, brought to you by Business Monitor InternationalOVERVIEW OF THE PHARMACEUTICAL MARKET IN UKRAINEForeign and domestic drugmakers in Ukraine will see their operating margins squeezed from2013as the Ministry of Health introduces more severe limitson mark-ups. Combined with the likely devaluation of the hryvnia, these factors represent a very large business risk for international drugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)'s more promising pharmaceutical markets given its favourable demographics and disease profile, its chronic lack of economic and political stability remains a critical impediment to fulfilling this potential.Headline Expenditure Projections Pharmaceuticals: UAH26.75bn (US$3.35bn) in 2011 to UAH30.79bn (US$3.75bn) in 2012; +15.1% in local currency terms and +12.1% in US dollar terms. Forecast unchanged from Q4 12. Healthcare: UAH96.98bn (US$12.14bn) in 2011 to UAH109.66bn (US$13.37bn) in 2012; +13.1% in local currency terms and +10.1% in US dollar terms. Forecast slightly up from Q4 12 on account of new historical figures. Medical devices: UAH6.38bn (US$799mn) in 2011 to UAH7.39bn (US$901mn) in 2012; +15.8% in local currency terms and +12.8% in US dollar terms. Forecast slightly up from Q4 12 on account of new historical figures. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Ukraine, Business Monitor International
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UKRAINE
Foreign and domestic drugmakers in Ukraine will see their operating margins squeezed from2013as the Ministry of Health introduces
more severe limitson mark-ups. Combined with the likely devaluation of the hryvnia, these factors represent a very large business risk
for international drugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)'s more
promising pharmaceutical markets given its favourable demographics and disease profile, its chronic lack of economic and political
stability remains a critical impediment to fulfilling this potential.
Headline Expenditure Projections
Pharmaceuticals: UAH26.75bn (US$3.35bn) in 2011 to UAH30.79bn (US$3.75bn) in 2012; +15.1% in local currency terms and
+12.1% in US dollar terms. Forecast unchanged from Q4 12.
Healthcare: UAH96.98bn (US$12.14bn) in 2011 to UAH109.66bn (US$13.37bn) in 2012; +13.1% in local currency terms and +10.1%
in US dollar terms. Forecast slightly up from Q4 12 on account of new historical figures.
Medical devices: UAH6.38bn (US$799mn) in 2011 to UAH7.39bn (US$901mn) in 2012; +15.8% in local currency terms and +12.8%
in US dollar terms. Forecast slightly up from Q4 12 on account of new historical figures.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
Ukraine Pharmaceutical And Healthcare Industry SWOT 7
Ukraine Political SWOT 8
Ukraine Economic SWOT 9
Ukraine Business Environment SWOT 10
Pharmaceutical Risk/Reward Ratings 11
Table: Emerging Europe ' Regional Pharmaceutical Risk/Reward Ratings, Q113 11
The Pharmaceutical Market: Ukraine, Business Monitor International (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Rewards 12
Risks 13
Market Overview 15
Regulatory Regime 16
Recent Regulatory Amendments 18
Pharmaceutical Advertising 20
Intellectual Property Issues 21
Counterfeit Drugs 22
Pricing Regime 23
Recent Pricing Regime Developments 25
Reimbursement Regime 28
Drug Tendering Regime 29
Industry Developments 31
Epidemiology 31
Table: Selected Causes of Death, 2005-2010 (000's) 31
Table: Morbidity by Selected Diseases, 2005-2010 (000's) 32
Public Health Developments 33
Healthcare System 33
Healthcare Funding 34
Healthcare System Reform 34
Health Insurance Developments 35
Healthcare Provision 36
Table: Number of Outpatient Facilities, 1995-2010 36
Research and Development (R&D) 37
Clinical Trials 39
Medical Devices 39
Industry Forecast Scenario 41
Pharmaceutical Market Forecast 41
Table: Pharmaceutical Sales, Historical Data and Forecasts 43
Healthcare Market Forecast 44
Table: Healthcare Expenditure Trends, Historical Data and Forecasts 48
Table: Government Healthcare Expenditure Trends, Historical Data and Forecasts 48
Table: Private Healthcare Expenditure Trends, Historical Data and Forecasts 49
Key Growth Factors ' Macroeconomic 50
Prescription Drug Market Forecast 53
Table: Ukraine Prescription Drug Market Indicators, Historical Data and Forecasts 54
Patented Drug Market Forecast 55
Table: Patented Drug Market Indicators, Historical Data and Forecasts 56
Generic Drug Market Forecast 57
Table: Generics Drug Market Indicators, Historical Data and Forecasts 58
OTC Medicine Market Forecast 59
Table: OTC Medicine Market Indicators, Historical Data and Forecasts 60
Pharmaceutical Trade Forecast 61
Table: Pharmaceutical Trade Data And Forecasts (US$mn) 63
Table: Pharmaceutical Trade Data And Forecasts (UAHmn) 63
Medical Device Market Forecast 64
Table: Medical Device Market Indicators, Historical Data and Forecasts 65
Other Healthcare Data 66
The Pharmaceutical Market: Ukraine, Business Monitor International (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Key Risks to Forecasts 67
Competitive Landscape 68
Pharmaceutical Industry 68
Table: Retail Pharmacy Sales Value & Volume, 2004-2010 (Million) 69
Table: Retail Pharmacy Sales Value by Leading Company, 2007-2010 (UAH Million) 69
Table: Retail Pharmacy Sales Value & Volume by Origin, 2010 (Million) 70
Table: Retail Pharmacy Sales Volume by Leading Company, 2010 (Million) 70
Domestic Pharmaceutical Sector 72
Foreign Pharmaceutical Sector 75
Table: Association of International Manufacturers (AIPM) Ukraine Members, 2011 75
Recent Company Activities 77
Pharmaceutical Wholesale 78
Pharmaceutical Retail 79
Company Profiles 82
Arterium 82
Gedeon Richter 84
Krka 86
Lek (Novartis/Sandoz) 88
Table: Ukraine's Population By Age Group, 1990-2020 ('000) 91
Table: Ukraine's Population By Age Group, 1990-2020 (% of total) 92
Table: Ukraine's Key Population Ratios, 1990-2020 93
Table: Ukraine's Rural And Urban Population, 1990-2020 93
Glossary 94
BMI Methodology 96
How We Generate Our Pharmaceutical Industry Forecasts 96
Pharmaceuticals Risk/Reward Ratings Methodology 97
Ratings Overview 97
Table: Pharmaceutical Risk/Reward Ratings Indicators 98
Weighting 99
Table: Weighting Of Components 99
Sources 99
The Pharmaceutical Market: Ukraine, Business Monitor International (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Ukraine, Business Monitor International
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Ukraine, Business Monitor International (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Ukraine, Business Monitor International (From Slideshare) Page 5/5